Eloxx Pharmaceuticals Competitors and Similar CompaniesClear all

Eloxx Pharmaceuticals's competitors and similar companies include Vertex Pharmaceuticals, Ginkgo Bioworks Holdings, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical and Igenomix.

	Eloxx Pharmaceuticals Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for rare genetic diseases.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	Ginkgo Bioworks Holdings Ginkgo Bioworks Holdings is a company that designs and develops genetic technology solutions.	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.	Igenomix Igenomix is a reproductive genetics company.
Founding Date	Founding Date 1999	Founding Date 1989	Founding Date 2020	Founding Date 1996	Founding Date 2012
Type	Type Public	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech genetics	Tags Healthcare biotech drug development pharma	Tags Technology biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics
Locations	Locations HQ Rehovot, IL Waltham, US	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations Boston, US HQ	Locations CN HQ	Locations Paterna, ES HQ New Delhi, IN Marostica, IT Ciudad De México, MX Dubai, AE see more
Employees	Employees 1044% decrease	Employees 5,40013% increase	Employees 1,2186% decrease	Employees 921	Employees 320
Valuation ($)	Valuation ($) 629	Valuation ($) 121.4 b	Valuation ($) 459.6 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $12b (FY, 2025)	Revenue (est.) $170.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods $47m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $10.4b (FY, 2025)	Gross profit $123.2m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($6m) (FY, 2025)	Net income N/A	Net income ($312.8m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 30m	Total funding raised $ 2.4m	Total funding raised $ 789.1m	Total funding raised N/A	Total funding raised N/A